Cargando…
Improved MHC II epitope prediction — a step towards personalized medicine
Numerous neoepitope-based vaccination strategies are in testing for clinical use in the treatment of cancer. Rapid identification of immunostimulatory neoantigen targets hastens neoantigen vaccine development. Papers recently published in Nature Biotechnology describe two independent machine-learnin...
Autores principales: | Moore, Tamson V., Nishimura, Michael I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7223749/ https://www.ncbi.nlm.nih.gov/pubmed/31836878 http://dx.doi.org/10.1038/s41571-019-0315-0 |
Ejemplares similares
-
Toward personalized TGFβ inhibition for pancreatic cancer
por: Carr, Ryan M, et al.
Publicado: (2019) -
Congress Statement on the Appraisal and Prospects for Person-Centered Medicine in Croatia
por: Đorđević, Veljko, et al.
Publicado: (2014) -
Small steps forward for HIV vaccine development
por: Mothe, Beatriz, et al.
Publicado: (2020) -
Towards comprehensive characterization of HER2 overexpression
por: Berezov, Alan, et al.
Publicado: (2006) -
Protein subnetwork markers improve prediction of cancer outcome
por: Auffray, Charles
Publicado: (2007)